Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CARE RatingsBOM:534804 -1.32%84 Return-on-Tangible-Asset is 11.93% as of Jun. 2026, which is 20% below its 10-year median of 14.84. GuruFocus rates BOM:534804 with a GF Score™ of 84/100 and a GF Value™ of ₹1,768.54 (Fairly Valued). The stock has 1 warning sign investors should review. Among 811 Capital Markets companies, CARE Ratings ranks better than 90.75% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. CARE Ratings's annualizedNet Income for the quarter that ended in Jun. 2026 was ₹1,290 Mil. CARE Ratings's average total tangible assets for the quarter that ended in Jun. 2026 was ₹10,815 Mil. Therefore, CARE Ratings's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 11.93%.
The historical rank and industry rank for CARE Ratings's Return-on-Tangible-Asset or its related term are showing as below:
BOM:534804'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 10.95 Med: 14.84 Max: 26.74
Current: 17.55
During the past 13 years, CARE Ratings's highest Return-on-Tangible-Asset was 26.74%. The lowest was 10.95%. And the median was 14.84%.
BOM:534804's Return-on-Tangible-Asset is ranked better than 90.75% of 811
companies
in the Capital Markets industry
Industry Median: 1.61
vs BOM:534804: 17.55
CARE Ratings (BOM:534804) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
CARE Ratings Return-on-Tangible-Asset Related Terms
CARE Ratings Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for CARE Ratings's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:534804 vs SPGI, CME, ICE: Return-on-Tangible-Asset Comparison
For the Financial Data & Stock Exchanges subindustry, CARE Ratings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CARE Ratings Return-on-Tangible-Asset vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CARE Ratings's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where CARE Ratings's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 11.93% mean?
CARE Ratings (BOM:534804) has a Return-on-Tangible-Asset of 11.93% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on CARE Ratings and its competitors. This is 20% below median its historical median of 14.84. Over the past decade, CARE Ratings' Return-on-Tangible-Asset has ranged from 10.95 to 26.74. According to the industry distribution chart, CARE Ratings ranks #75 out of 811 companies in the Capital Markets industry, placing it in the top 9.2%.
Is CARE Ratings' Return-on-Tangible-Asset too high?
CARE Ratings' current Return-on-Tangible-Asset of 11.93% is 20% below median its 10-year median of 14.84. Over the past 10 years, this metric has ranged from a low of 10.95 to a high of 26.74. The Capital Markets industry median Return-on-Tangible-Asset is 1.61. CARE Ratings' value of 11.93% is 641% above this industry median. Based on the distribution chart, CARE Ratings ranks #75 out of 811 companies in the Capital Markets industry, which is in the top quartile — a strong position relative to peers. Overall, CARE Ratings has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CARE Ratings' Return-on-Tangible-Asset compare to SPGI and CME?
According to the Capital Markets industry distribution chart, CARE Ratings ranks #75 out of 811 companies for Return-on-Tangible-Asset. This places CARE Ratings in the top 9% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 1.61. CARE Ratings' value of 11.93% is 641% above this benchmark. Historically, CARE Ratings' own Return-on-Tangible-Asset has ranged from 10.95 to 26.74 over the past decade. While the company's 10-year median is 14.84 vs. the industry median of 1.61, CARE Ratings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Capital Markets company?
The median Return-on-Tangible-Asset among Capital Markets companies is 1.61, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CARE Ratings's current Return-on-Tangible-Asset of 11.93% is 641% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on CARE Ratings and its competitors. For the Capital Markets industry, the median Return-on-Tangible-Asset is 1.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CARE Ratings's current Return-on-Tangible-Asset is 11.93%, which is 20% below median its own 10-year median of 14.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CARE Ratings stock overvalued right now?
Based on GuruFocus' analysis, CARE Ratings (BOM:534804) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,768.54, compared to a current price of ₹1,683.85 — trading 4.8% below its estimated fair value. The current Return-on-Tangible-Asset is 11.93%, which is 20% below median its 10-year median of 14.84 and 641% above the Capital Markets industry median of 1.61. CARE Ratings' overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For CARE Ratings (BOM:534804), the current Return-on-Tangible-Asset is 11.93% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CARE Ratings (BOM:534804) Overvalued in 2026?
Based on GuruFocus' analysis, CARE Ratings stock appears to be undervalued.
The current stock price of ₹1,683.85 is trading 4.8% below its estimated GF Value™ of ₹1,768.54.
GuruFocus considers CARE Ratings to be Fairly Valued.
Key valuation signals for BOM:534804:
Return-on-Tangible-Asset: 11.93% (20% below median its 10-year median of 14.84)
GF Value™: ₹1,768.54 vs. price of ₹1,683.85 (4.8% below fair value)
Industry Position: 641% above the Capital Markets median (#75 of 811)
No single metric tells the full story. See the BOM:534804 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CARE Ratings Ltd provides various credit ratings that helps corporates to raise capital for their various requirements and assists the investors to form an informed investment decision based on the credit risk and their own risk-return expectations. The company works in Bank Loan Ratings; Capital Market Instruments, Including NCDs/ Bonds/ Hybrids/ CPs/CDs, etc; Structured Finance Ratings; Monitoring Agency Services for Equity Capital; Rating of REITs /InvITs; Resolution Plan Ratings; Recovery Ratings; Issuer Ratings. The company's segment includes Ratings and related services; and Others. The company generates majority of revenue from Ratings and related services. The company has presence in India, and Outside India. It generates majority of revenue from India.
84GF Score
Get the complete analysis for BOM:534804
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:534804 has been successfully added to your 
